Aspira Women's Health Inc... (AWH)
NASDAQ: AWH
· Real-Time Price · USD
0.08
-0.00 (-2.44%)
At close: Apr 16, 2025, 3:57 PM
Aspira Women's Health Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.18M | 8.96M | 8.92M | 8.99M | 9.15M | 9.18M | 9.03M | 8.61M | 8.18M | 7.88M | 7.48M | 7.21M | 6.81M | 6.41M | 5.98M | 4.93M |
Cost of Revenue | 3.7M | 3.75M | 3.76M | 3.7M | 3.89M | 3.89M | 3.9M | 4.06M | 3.87M | 3.79M | 3.79M | 3.79M | 3.75M | 4.13M | 4.02M | 3.51M |
Gross Profit | 5.48M | 5.21M | 5.16M | 5.29M | 5.27M | 5.28M | 5.13M | 4.55M | 4.32M | 4.1M | 3.69M | 3.42M | 3.06M | 2.28M | 1.96M | 1.42M |
Operating Income | -16.28M | -16.98M | -17.35M | -17.28M | -18.34M | -19.81M | -25.39M | -29.29M | -32.77M | -36.11M | -36.1M | -35.96M | -32.59M | -29.72M | -24.31M | -20.07M |
Interest Income | n/a | n/a | 12K | 20K | 46K | 73K | 79K | 71K | 45K | 18K | n/a | n/a | n/a | n/a | 5K | 5K |
Pretax Income | -13.09M | -14.79M | -15.95M | -14.74M | -16.18M | -18.19M | -18.04M | -23.97M | -27.17M | -31.03M | -36.18M | -35.01M | -31.66M | -28.78M | -23.36M | -20.12M |
Net Income | -13.09M | -14.79M | -15.95M | -14.74M | -16.45M | -18.01M | -17.86M | -23.81M | -26.76M | -31.07M | -36.22M | -35.03M | -31.66M | -28.78M | -23.36M | -20.12M |
Selling & General & Admin | 18.49M | 18.35M | 18.58M | 18.9M | 19.61M | 21.13M | 25.4M | 28M | 31.13M | 33.84M | 34.06M | 33.59M | 30.34M | 27.41M | 22.6M | 18.91M |
Research & Development | 3.27M | 3.84M | 3.93M | 3.67M | 4M | 3.96M | 5.12M | 5.84M | 5.95M | 6.37M | 5.73M | 5.79M | 5.31M | 4.59M | 3.67M | 2.58M |
Other Expenses | -165K | -1.47M | -869K | 135K | n/a | 1.31M | 826K | -191K | 106K | 99K | -20K | 988K | 981K | 980K | 971K | -30K |
Operating Expenses | 21.76M | 22.19M | 22.52M | 22.57M | 23.61M | 25.09M | 30.52M | 33.84M | 37.08M | 40.21M | 39.79M | 39.38M | 35.66M | 32M | 26.27M | 21.49M |
Interest Expense | 20K | 20K | 15K | 13K | 34K | 34K | 34K | 36K | 28K | 76K | 90K | 83K | 89K | 41K | 27K | 25K |
Selling & Marketing Expenses | 8.15M | 7.89M | 7.45M | 7.09M | 7.76M | 8.96M | 11.21M | 13.01M | 14.95M | 16.9M | 18.04M | 18.48M | 17.09M | 15.05M | 12.12M | 9.84M |
Cost & Expenses | 25.46M | 25.95M | 26.28M | 26.27M | 27.5M | 28.98M | 34.42M | 37.89M | 40.95M | 43.99M | 43.58M | 43.16M | 39.41M | 36.13M | 30.29M | 24.99M |
Income Tax Expense | -14.28K | 753.72K | 713.72K | -286.28K | n/a | -1.22M | -6.21M | -5.18M | -5.43M | -4.93M | 106K | 80K | -7K | -138K | -157K | -155K |
Shares Outstanding (Basic) | 14.13M | 15.41M | 12.52M | 11.85M | 10.41M | 9.78M | 8.4M | 8.31M | 553.75K | 7.81M | 7.48M | 7.48M | 7.47M | 7.19M | 7.46M | 7.24M |
Shares Outstanding (Diluted) | 14.13M | 15.41M | 12.52M | 11.85M | 10.41M | 9.78M | 8.4M | 8.31M | 553.75K | 7.81M | 7.48M | 7.48M | 7.47M | 7.47M | 7.46M | 7.24M |
EPS (Basic) | -1 | -1.2 | -1.45 | -1.45 | -1.82 | -9.91 | -10.01 | -10.83 | -11.31 | -4.12 | -4.89 | -4.74 | -4.32 | -4.06 | -3.33 | -2.97 |
EPS (Diluted) | -1 | -1.2 | -1.45 | -1.45 | -1.82 | -9.91 | -10.01 | -10.83 | -11.31 | -4.12 | -4.84 | -4.69 | -4.27 | -3.98 | -3.3 | -2.94 |
EBITDA | -17.37M | -16.89M | -17.22M | -17.12M | -18.65M | -20.09M | -24.52M | -28.41M | -31.38M | -34.73M | -35.85M | -35.68M | -32.3M | -29.39M | -23.99M | -19.77M |
EBIT | -17.44M | -16.98M | -17.35M | -17.28M | -18.85M | -20.32M | -24.78M | -28.68M | -31.65M | -34.99M | -36.1M | -35.96M | -32.6M | -29.74M | -24.33M | -20.08M |
Depreciation & Amortization | 92K | 115K | 132K | 164K | 206K | 239K | 266K | 274K | 269K | 265K | 267K | 299K | 339K | 360K | 355K | 315K |